{"errors":{},"id":6270633,"source_code":"GOOG","source_name":"Google Finance","code":"FRA_CUR","name":"curasan AG (CUR)","urlize_name":"curasan-AG-CUR","description":"curasan AG is a Germany-based company that specializes in the production and distribution of drugs and medical products. The Company operates in such fields as dental implants, bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. cursan AG divides its business activities into the two segments: Pharmaceuticals and Biomaterials. Pharmaceuticals segment includes primarily the product Mitem, a drug for the treatment of urinary bladder cancer. Biomaterials segment's portfolio comprises Stypro, gelatin sponge for the control and wound healing; Curavisc, which is used for the treatment of joint arthrosis; Cerasorb, a synthetic bone substitution and regeneration material; Osbone, a spongious bone substitute, and ATR, which supports tissue regeneration. In the dental field, Cerasorb is marketed by Riemser Arzneimittel AG","updated_at":"2014-06-02T02:01:54Z","frequency":"daily","from_date":"2011-01-03","to_date":"2014-05-30","column_names":["Date","Open","High","Low","Close","Volume"],"private":false,"type":null,"display_url":"http://www.google.com/finance/historical?q=FRA%3ACUR&startdate=Jan+1%2C+1990&output=csv"}